Chevron Technology Ventures has invested in two alternative energy startups. Photo via Getty Images

The venture arm of Chevron has made two recent investments as a part of a new fund. Both of the companies are creating solutions within alternative energy innovation.

Chevron Technology Ventures announced its $300 million Future Energy Fund II in February, and the two recent investments represent the first moves made by the new fund.

The first investment was in Denver-based Starfire Energy, which develops modular chemical plants for the production of carbon-free ammonia and carbon-free hydrogen. The company closed its funding round earlier this month at an undisclosed amount. The round was led AP Ventures, which focuses on hydrogen production, storage, and transportation innovations, with contributions from CTV, New Energy Technologies, Osaka Gas USA, and Mitsubishi Heavy Industries.

"Our investment in Starfire Energy gives us visibility into green hydrogen's potential to improve the way ammonia is produced, distributed, and consumed," says Barbara Burger, vice president of innovation and president of CTV, in a news release. "This is the first investment from our new $300 million Future Energy Fund II, which will focus on industrial decarbonization, emerging mobility, energy decentralization, and the growing circular carbon economy."

The funds will be used to scale operations to decarbonize ammonia production and and move it forward as a zero-carbon energy carrier. According to the release, ammonia has a lot of potential within the alternative energy space. It has an energy density "comparable to fossil fuels and significantly higher than Li-ion batteries, compressed, or liquid hydrogen." Additionally, it's cheap to transport and store.

The second investment, which was finalized this week, was into a Nevada-based company that is developing low-cost floating wind turbines. Ocergy Inc.Inc.'s series A, which didn't have its value disclosed, was invested in by Moreld Ocean Wind and CTV.

"We are delighted about this partnership as it will allow Ocergy to advance and commercialize its innovative technologies," says Ocergy CEO Dominique Roddier in a news release. "With MOW onboard we gain a trusted partner who will be able to provide an EPCI solution for OCG-Wind, a key requirement for many of our clients. We are excited to have gained Chevron's investment and look forward to potential opportunities for their guidance and expertise executing some of the most complex offshore projects in the world."

Ocergy's floating wind turbines are low-cost. Photo via release

The company will use the funds for growth and commercialization.

"Offshore wind power is undergoing a period of rapid innovation in an effort to provide lower carbon energy at a substantial scale," Burger says. "Ocergy has developed technology that could be part of the solution to enable more affordable, reliable, and ever-cleaner energy in a marine environment."

Future Energy Fund II is the eighth venture fund created by Chevron Technology Ventures since its establishment in 1999. In 2019, the investment arm started a $90 million fund to invest in startups that can help accelerate the oil and gas business of San Ramon, California-based Chevron.

Barbara Burger is vice president of innovation at Chevron and president of CTV. Photo courtesy of CTV

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”

Chevron enters the lithium market with major Texas land acquisition

to market

Chevron U.S.A., a subsidiary of Houston-based energy company Chevron, has taken its first big step toward establishing a commercial-scale lithium business.

Chevron acquired leaseholds totaling about 125,000 acres in Northeast Texas and southwest Arkansas from TerraVolta Resources and East Texas Natural Resources. The acreage contains a high amount of lithium, which Chevron plans to extract from brines produced from the subsurface.

Lithium-ion batteries are used in an array of technologies, such as smartwatches, e-bikes, pacemakers, and batteries for electric vehicles, according to Chevron. The International Energy Agency estimates lithium demand could grow more than 400 percent by 2040.

“This acquisition represents a strategic investment to support energy manufacturing and expand U.S.-based critical mineral supplies,” Jeff Gustavson, president of Chevron New Energies, said in a news release. “Establishing domestic and resilient lithium supply chains is essential not only to maintaining U.S. energy leadership but also to meeting the growing demand from customers.”

Rania Yacoub, corporate business development manager at Chevron New Energies, said that amid heightening demand, lithium is “one of the world’s most sought-after natural resources.”

“Chevron is looking to help meet that demand and drive U.S. energy competitiveness by sourcing lithium domestically,” Yacoub said.

---

This article originally appeared on EnergyCapital.